Dupixent

FDA approves new eczema drug Dupixent | PRIME Journal, Food and Drug Administration Approves Dupixent, First Drug, Biologic Therapy Dupixent (Dupilumab) Approved For Atopic, Practical Dermatology – Recent Developments (April 2017), Trenton, NJ – FDA Approves 1st Drug For Moderate & Severe, DUPIXENT Trademark of Sanofi Biotechnology. Serial Number, Dupixent – FDA prescribing information, side effects and uses, Dupixent Review – Revolutionary FDA-Approved Eczema Drug, FDA approves 1st drug for moderate & severe eczema cases, Fixed Drug Eruptions Clinical Presentation: History, New Drug Product: Dupixent, Biologic Therapy Dupixent (Dupilumab) Approved For Atopic, Biologic Therapy Dupixent (Dupilumab) Approved For Atopic.